Literature DB >> 29120862

MicroRNAs participate in the regulation of oligodendrocytes development in white matter injury.

Dongqiong Xiao1, Yi Qu1, Lingli Pan1, Xihong Li1, Dezhi Mu1.   

Abstract

White matter injury (WMI) often results in cognitive impairment, behavioral disorders, and cerebral palsy and thus imposes a tremendous burden on society. The cells in brain white matter mainly comprise oligodendrocytes (OLs), astrocytes, and microglia. The dysregulation of OLs development is the pathological hallmark of WMI. Recent studies have demonstrated that microRNAs (miRNAs or miRs) participate in the regulation of OLs development, and the dysregulation of this process represents the pathogenesis of WMI. This review summarizes the progress made in this field that will help clinicians and researchers understand the molecular etiology of WMI and develop miRNAs as new agents for the prevention and treatment of WMI.

Entities:  

Keywords:  developmental; microRNAs; oligodendrocyte; white matter injury

Mesh:

Substances:

Year:  2018        PMID: 29120862     DOI: 10.1515/revneuro-2017-0019

Source DB:  PubMed          Journal:  Rev Neurosci        ISSN: 0334-1763            Impact factor:   4.353


  2 in total

1.  M2 microglia-derived extracellular vesicles promote white matter repair and functional recovery via miR-23a-5p after cerebral ischemia in mice.

Authors:  Yongfang Li; Ze Liu; Yaying Song; Jia-Ji Pan; Yixu Jiang; Xiaojing Shi; Chang Liu; Yuanyuan Ma; Longlong Luo; Muyassar Mamtilahun; Zhiyu Shi; Haroon Khan; Qing Xie; Yongting Wang; Yaohui Tang; Zhijun Zhang; Guo-Yuan Yang
Journal:  Theranostics       Date:  2022-04-24       Impact factor: 11.600

2.  Genetic Deficiency of MicroRNA-15a/16-1 Confers Resistance to Neuropathological Damage and Cognitive Dysfunction in Experimental Vascular Cognitive Impairment and Dementia.

Authors:  Chao Zhou; Ping Sun; Yang Xu; Yuang Chen; Yixian Huang; Milton H Hamblin; Lesley Foley; T Kevin Hitchens; Song Li; Ke-Jie Yin
Journal:  Adv Sci (Weinh)       Date:  2022-04-11       Impact factor: 17.521

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.